Centaurus Financial, Inc. Pro Qr Therapeutics N.V. Transaction History
Centaurus Financial, Inc.
- $1.37 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding PRQR
# of Institutions
52Shares Held
17.2MCall Options Held
26.2KPut Options Held
8.6K-
Privium Fund Management B.V.5.58MShares$10.4 Million2.62% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$6.78 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.04MShares$3.82 Million0.12% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$1.91 Million1.95% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$1.69 Million0.39% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $133M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...